However, pre-biologic BEC and FeNO were strongly associated with lung function improvement for both anti-IgE and anti-IL5/5R therapies, with BEC also associated with improved asthma control for patients treated with anti-IL5/5R therapies. The gene discussed is IL5; the disease is asthma.